Gliatech stops sale of gel after supplier recall:
This article was originally published in Clinica
Gliatech has temporarily halted worldwide distribution of its anti-adhesion gel ADCON-L, and ADCON-T/N, which is approved outside the US. The voluntarily move was prompted by the recall by a supplier of a raw material used in the ADCON products. As a result, the FDA has issued an import alert concerning ADCON-L, the Cleveland, Ohio company says. Gliatech is carrying out quality controls and will only resume distribution of the products once its findings have been reviewed by the FDA. The company remains confident that its product is safe.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.